TY - JOUR T1 - The role of HIV infection in the clinical spectrum of COVID-19: a population-based cohort analysis based on US National COVID Cohort Collaborative (N3C) Enclave data JF - medRxiv DO - 10.1101/2021.06.03.21258324 SP - 2021.06.03.21258324 AU - Xueying Yang AU - Jiajia Zhang AU - Siyuan Guo AU - Bankole Olatosi AU - Sharon Weissman AU - Xiaoming Li Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/06/24/2021.06.03.21258324.abstract N2 - The authors have withdrawn this manuscript because of the accidental low cell size in the supplementary materials. Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe analyses described in this publication were conducted with data or tools accessed through the NCATS N3C Data Enclave https://covid.cd2h.org and supported by NCATS U24 TR002306 and the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number R01AI127203-4S1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:An Institutional Data Use Agreement was signed between University of South Carolina and National Center for Advancing Translational Sciences (NCATS) N3C Data Enclave and our study protocol received approval from the institutional review board in University of South Carolina.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNational Institute of Health (NIH) National COVID Cohort Collaborative (N3C) has clear procedures for researchers to gain access to the data (1000+ researchers already have access to the data) and as such the patient statistical analysis of this manuscript is transparent and repeatable. ER -